Corcept Therapeutics Inc (CORT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$39.90

Buy

$40.80

arrow-up$2.19 (+5.75%)

Prices updated at 31 Mar 2026, 14:25 EDT

Prices minimum 15 mins delay

Prices in USD

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

NASDAQ

3.83%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	675m	761m
	664m	748m
	137m	45m
	20.29	5.88
	141m	100m
	138m	47m
Sales, General and administrative	280m	449m
Interest expenses	-	-
Provision for income taxes	20m	-33m
Operating expenses	527m	704m
Income before taxes	161m	66m
Net income available to common shareholders	140m	98m
	1.35	0.95
Net interest income	25m	22m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.23	0.82
Free cash flow per share	1.2803	1.3615
Book value/share	6.0776	5.9633
Debt equity ratio	0.008986	0.007754

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	472m	485m
Current liabilities	141m	166m
Total capital	680m	648m
Total debt	7m	6m
Total equity	680m	648m
Total non current liabilities	-	-
Loans	-	-
Total assets	841m	837m
Total liabilities	-	-
Cash and cash equivalents	128m	120m
Common stock	105m	106m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	136m	128m
Cash dividends paid	-	-
	196m	142m
Investments (gains) losses	-178m	70m
	128m	120m
Net income	-	-
	198m	142m
	-2m	-211,000

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.